Raytel to buy cardiovascular center firm
Raytel Medical has signed a letter of intent to acquire Cardiovascular Ventures of New Orleans, an operator of cardiovascular diagnostic facilities in Texas, Louisiana, and Maryland. The proposed agreement fits Raytel's new business strategy of expanding
Raytel Medical has signed a letter of intent to acquire Cardiovascular Ventures of New Orleans, an operator of cardiovascular diagnostic facilities in Texas, Louisiana, and Maryland. The proposed agreement fits Raytel's new business strategy of expanding in the cardiovascular center market by building a network of integrated heart centers. Cardiovascular Ventures had revenues of about $17.3 million and was profitable for the first nine months of the fiscal year (end-June). Raytel in May said it was evaluating its options in its other business, the operation of medical imaging centers, which it may divest to concentrate on its heart center network (SCAN 5/14/97).
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.
SNMMI: Botox May Facilitate Relief from Dry Mouth Side Effect of PSMA-Targeted Radiopharmaceuticals
June 25th 2025For patients being treated with radiopharmaceutical agents for metastatic prostate cancer, the combination of botulinum toxin and an anti-nausea patch led to a 30 percent reduction in PSMA uptake in the salivary glands, according to preliminary research findings presented at the SNMMI conference.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
